High Prices For Orphan Drugs Strain Families And Insurers
Three decades ago, Congress set up a system to encourage drug companies to develop treatments for rare diseases. The law has worked but at a high cost.
Read more on NPR
Health Care - January 18, 2017 at 01:35AM - High Prices For Orphan Drugs Strain Families And Insurers
Không có nhận xét nào:
Đăng nhận xét